BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 24756113)

  • 1. Graphene Functionalized with Arginine Decreases the Development of Glioblastoma Multiforme Tumor in a Gene-Dependent Manner.
    Sawosz E; Jaworski S; Kutwin M; Vadalasetty KP; Grodzik M; Wierzbicki M; Kurantowicz N; Strojny B; Hotowy A; Lipińska L; Jagiełło J; Chwalibog A
    Int J Mol Sci; 2015 Oct; 16(10):25214-33. PubMed ID: 26512645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TSPO ligand residence time influences human glioblastoma multiforme cell death/life balance.
    Costa B; Da Pozzo E; Giacomelli C; Taliani S; Bendinelli S; Barresi E; Da Settimo F; Martini C
    Apoptosis; 2015 Mar; 20(3):383-98. PubMed ID: 25413799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission tomography and functional characterization of a complete PBR/TSPO knockout.
    Banati RB; Middleton RJ; Chan R; Hatty CR; Kam WW; Quin C; Graeber MB; Parmar A; Zahra D; Callaghan P; Fok S; Howell NR; Gregoire M; Szabo A; Pham T; Davis E; Liu GJ
    Nat Commun; 2014 Nov; 5():5452. PubMed ID: 25406832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral benzodiazepine receptor/translocator protein global knock-out mice are viable with no effects on steroid hormone biosynthesis.
    Tu LN; Morohaku K; Manna PR; Pelton SH; Butler WR; Stocco DM; Selvaraj V
    J Biol Chem; 2014 Oct; 289(40):27444-54. PubMed ID: 24936060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxaliplatin(IV) Prodrugs Functionalized with Gemcitabine and Capecitabine Induce Blockage of Colorectal Cancer Cell Growth-An Investigation of the Activation Mechanism and Their Nanoformulation.
    Marotta C; Cirri D; Kanavos I; Ronga L; Lobinski R; Funaioli T; Giacomelli C; Barresi E; Trincavelli ML; Marzo T; Pratesi A
    Pharmaceutics; 2024 Feb; 16(2):. PubMed ID: 38399332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomaterial-based
    Ahmed T
    Cancer Pathog Ther; 2023 Jul; 1(3):177-194. PubMed ID: 38327839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sexually dimorphic murine brain uptake of the 18 kDa translocator protein PET radiotracer [
    Knyzeliene A; Wimberley C; MacAskill MG; Alcaide-Corral CJ; Morgan TEF; Henry MC; Lucatelli C; Pimlott SL; Sutherland A; Tavares AAS
    Brain Commun; 2024; 6(1):fcae008. PubMed ID: 38304004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipose-derived stem cells repair radiation-induced chronic lung injury via inhibiting TGF-β1/Smad 3 signaling pathway.
    Huang X; Sun W; Nie B; Li JJ; Jing F; Zhou XL; Ni XY; Ni XC
    Open Med (Wars); 2023; 18(1):20230850. PubMed ID: 38025537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Systematic Review of Glioblastoma-Targeted Therapies in Phases II, III, IV Clinical Trials.
    Cruz Da Silva E; Mercier MC; Etienne-Selloum N; Dontenwill M; Choulier L
    Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33918704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson's Disease Patients and Correlate with Disease Severity.
    Daniele S; Frosini D; Pietrobono D; Petrozzi L; Lo Gerfo A; Baldacci F; Fusi J; Giacomelli C; Siciliano G; Trincavelli ML; Franzoni F; Ceravolo R; Martini C; Bonuccelli U
    Front Mol Neurosci; 2018; 11():53. PubMed ID: 29520218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human glioblastoma multiforme: p53 reactivation by a novel MDM2 inhibitor.
    Costa B; Bendinelli S; Gabelloni P; Da Pozzo E; Daniele S; Scatena F; Vanacore R; Campiglia P; Bertamino A; Gomez-Monterrey I; Sorriento D; Del Giudice C; Iaccarino G; Novellino E; Martini C
    PLoS One; 2013; 8(8):e72281. PubMed ID: 23977270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TSPO as a target for glioblastoma therapeutics.
    Werry EL; Barron ML; Kassiou M
    Biochem Soc Trans; 2015 Aug; 43(4):531-6. PubMed ID: 26551689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-molecule inhibitors of the p53-MDM2 interaction.
    Vu BT; Vassilev L
    Curr Top Microbiol Immunol; 2011; 348():151-72. PubMed ID: 21046355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis therapy in cancer: the first single-molecule co-activating p53 and the translocator protein in glioblastoma.
    Daniele S; Taliani S; Da Pozzo E; Giacomelli C; Costa B; Trincavelli ML; Rossi L; La Pietra V; Barresi E; Carotenuto A; Limatola A; Lamberti A; Marinelli L; Novellino E; Da Settimo F; Martini C
    Sci Rep; 2014 Apr; 4():4749. PubMed ID: 24756113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long lasting MDM2/Translocator protein modulator: a new strategy for irreversible apoptosis of human glioblastoma cells.
    Daniele S; Barresi E; Zappelli E; Marinelli L; Novellino E; Da Settimo F; Taliani S; Trincavelli ML; Martini C
    Oncotarget; 2016 Feb; 7(7):7866-84. PubMed ID: 26761214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lead Optimization of 2-Phenylindolylglyoxylyldipeptide Murine Double Minute (MDM)2/Translocator Protein (TSPO) Dual Inhibitors for the Treatment of Gliomas.
    Daniele S; La Pietra V; Barresi E; Di Maro S; Da Pozzo E; Robello M; La Motta C; Cosconati S; Taliani S; Marinelli L; Novellino E; Martini C; Da Settimo F
    J Med Chem; 2016 May; 59(10):4526-38. PubMed ID: 27050782
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.